Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Shoushtari
    Shoushtari
  8. Cheung
    Cheung
  9. Voss
    Voss
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (560)
  2. Solid Tumor Oncology Division (456)
  3. GSK Faculty (293)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (157)
  6. Hematologic Malignancies, Division of (155)
  7. Epidemiology and Biostatistics (152)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (120)
  10. Surgery (119)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (560)
  2. Solid Tumor Oncology Division (456)
  3. GSK Faculty (293)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (157)
  6. Hematologic Malignancies, Division of (155)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Sandra D'Angelo (25)

More People

Years
  1. 2025 (33)
  2. 2024 (60)
  3. 2023 (44)
  4. 2022 (122)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (407)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (47)
  5. Journal of Hematology & Oncology (43)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GUIP1: A R package for dose escalation strategies in phase I cancer clinical trials
    Journal Article

    Dinart, D.; Fraisse, J.; Tosi, D.; Mauguen, A.; Touraine, C.; Gourgou, S.; Le Deley, M. C.; Bellera, C.; Mollevi, C.
    BMC Medical Informatics and Decision Making (2020)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Journal Article

    Ged, Y.; Gupta, R.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    BMC Urology (2020)

    Fulltext@MSK | Save
  • A phase 1 dose escalation study of PRS-343, a HER2/4-1bb bispecific molecule, in patients with HER2-positive malignancies
    Meeting Abstract

    Piha-Paul, S.; Bendell, J.; Tolcher, A.; Hurvitz, S.; Patnaik, A.; Shroff, R.; Pohlmann, P.; Zettl, M.; Hahn, N.; Krishnamurthy, A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Construction of the immune landscape of durable response to checkpoint blockade therapy by integrating publicly available datasets
    Meeting Abstract

    Rudqvist, N. P.; Zappasodi, R.; Wells, D.; Thorsson, V.; Cogdill, A.; Monette, A.; Najjar, Y.; Sweis, R.; Wennerberg, E.; Bommareddy, P.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: Primary analysis of fixed-dosing, long-term outcome of weight-based dosing
    Journal Article

    Rischin, D.; Migden, M. R.; Lim, A. M.; Schmults, C. D.; Khushalani, N. I.; Hughes, B. G. M.; Schadendorf, D.; Dunn, L. A.; Hernandez-Aya, L.; Chang, A. L. S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer
    Journal Article

    Onishi, N.; Sadinski, M.; Hughes, M. C.; Ko, E. S.; Gibbs, P.; Gallagher, K. M.; Fung, M. M.; Hunt, T. J.; Martinez, D. F.; Shukla-Dave, A.; more...
    Breast Cancer Research (2020)

    Fulltext@MSK | Save
  • A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy
    Journal Article

    Sutton, E. J.; Onishi, N.; Fehr, D. A.; Dashevsky, B. Z.; Sadinski, M.; Pinker, K.; Martinez, D. F.; Brogi, E.; Braunstein, L.; Razavi, P.; more...
    Breast Cancer Research (2020)

    Fulltext@MSK | Save
  • Trans fatty acid intake among Chinese population: A longitudinal study from 1991 to 2011
    Journal Article

    Jiang, L.; Shen, J.; Zhao, Y.; Li, J.; Liu, S.; Liu, Y.; Wang, H.; Su, C.; Zhuang, X.; Chen, N.; more...
    Lipids in Health and Disease (2020)

    Fulltext@MSK | Save
  • PD1/PD-L1 targeting in advanced soft-tissue sarcomas: A pooled analysis of phase II trials
    Research Letter

    Italiano, A.; Bellera, C.; D'Angelo, S.
    Journal of Hematology & Oncology (2020)

    Fulltext@MSK | Save